Balentine LLC’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,412
| Closed | -$529K | – | 188 |
|
|
2024
Q3 | $529K | Buy |
8,412
+3,057
| +57% | +$178K | 0.02% | 96 |
|
|
2024
Q2 | $316K | Sell |
5,355
-4,954
| -48% | -$310K | 0.01% | 97 |
|
|
2024
Q1 | $822K | Buy |
10,309
+1,879
| +22% | +$144K | 0.02% | 213 |
|
|
2023
Q4 | $666K | Buy |
8,430
+572
| +7% | +$40.7K | 0.02% | 237 |
|
|
2023
Q3 | $549K | Buy |
7,858
+447
| +6% | +$31.7K | 0.02% | 249 |
|
|
2023
Q2 | $512K | Sell |
7,411
-3,545
| -32% | -$252K | 0.02% | 263 |
|
|
2023
Q1 | $814K | Sell |
10,956
-16,654
| -60% | -$1.4M | 0.03% | 221 |
|
|
2022
Q4 | $2.57M | Sell |
27,610
-8,687
| -24% | -$838K | 0.09% | 82 |
|
|
2022
Q3 | $3.46M | Sell |
36,297
-15,645
| -30% | -$1.55M | 0.13% | 48 |
|
|
2022
Q2 | $4.81M | Buy |
51,942
+19,198
| +59% | +$1.87M | 0.18% | 43 |
|
|
2022
Q1 | $3.31M | Buy |
32,744
+19,343
| +144% | +$2.03M | 0.11% | 45 |
|
|
2021
Q4 | $1.38M | Buy |
13,401
+2,481
| +23% | +$229K | 0.05% | 66 |
|
|
2021
Q3 | $927K | Buy |
10,920
+5,476
| +101% | +$459K | 0.04% | 70 |
|
|
2021
Q2 | $454K | Buy |
5,444
+2,561
| +89% | +$210K | 0.02% | 90 |
|
|
2021
Q1 | $217K | Buy |
+2,883
| New | +$210K | 0.01% | 133 |
|
|
2020
Q3 | – | Sell |
-1,575
| Closed | -$102K | – | 316 |
|
|
2020
Q2 | $102K | Buy |
1,575
+780
| +98% | +$49.1K | 0.01% | 150 |
|
|
2020
Q1 | $47K | Sell |
795
-324
| -29% | -$21.6K | ﹤0.01% | 186 |
|
|
2019
Q4 | $83K | Sell |
1,119
-2,288
| -67% | -$161K | ﹤0.01% | 134 |
|
|
2019
Q3 | $215K | Buy |
3,407
+3,068
| +905% | +$182K | 0.01% | 62 |
|
|
2019
Q2 | $18K | Sell |
339
-2,801
| -89% | -$151K | ﹤0.01% | 222 |
|
|
2019
Q1 | $169K | Sell |
3,140
-99
| -3% | -$6.11K | 0.01% | 63 |
|
|
2018
Q4 | $212K | Buy |
3,239
+3,059
| +1,699% | +$228K | 0.02% | 60 |
|
|
2018
Q3 | $14K | Buy |
+180
| New | +$12.9K | ﹤0.01% | 157 |
|
|
2018
Q2 | – | Sell |
-65
| Closed | -$4K | – | 120 |
|
|
2018
Q1 | $4K | Sell |
65
-2,720
| -98% | -$195K | ﹤0.01% | 55 |
|
|
2017
Q4 | $202K | Sell |
2,785
-717
| -20% | -$52.1K | 0.02% | 121 |
|
|
2017
Q3 | $285K | Buy |
3,502
+889
| +34% | +$70.3K | 0.02% | 87 |
|
|
2017
Q2 | $210K | Hold |
2,613
| – | – | 0.02% | 104 |
|
|
2017
Q1 | $205K | Buy |
2,613
+781
| +43% | +$62.4K | 0.02% | 102 |
|
|
2016
Q4 | $145K | Buy |
1,832
+1,164
| +174% | +$94.2K | 0.02% | 121 |
|
|
2016
Q3 | $59K | Sell |
668
-22
| -3% | -$2.08K | 0.01% | 158 |
|
|
2016
Q2 | $66K | Buy |
690
+122
| +21% | +$12.2K | 0.01% | 136 |
|
|
2016
Q1 | $59K | Hold |
568
| – | – | 0.02% | 100 |
|
|
2015
Q4 | $56K | Sell |
568
-560
| -50% | -$54.8K | 0.01% | 149 |
|
|
2015
Q3 | $109K | Buy |
1,128
+220
| +24% | +$23.1K | 0.02% | 92 |
|
|
2015
Q2 | $95K | Sell |
908
-1,483
| -62% | -$152K | 0.02% | 96 |
|
|
2015
Q1 | $247K | Buy |
+2,391
| New | +$242K | 0.05% | 38 |
|
Other funds holding CVS
Balentine LLC's CVS Position: Q4 2024 in Review
Balentine LLC sold out of CVS Health (CVS) in Q4 2024, closing a stake of 8,412 shares — an estimated $529K sold.
Balentine LLC first reported a position in CVS in Q1 2015 and held it in 36 quarters. The position peaked at $4.81M in Q2 2022. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Balentine LLC reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Balentine LLC sold 8,412 CVS Health shares in Q4 2024, an estimated $529K.
- Balentine LLC first reported a position in CVS Health in Q1 2015 and held it in 36 quarters.
- Balentine LLC's CVS Health position peaked at $4.81M in Q2 2022.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Balentine LLC's 13F filing for Q4 2024, filed 29 Jan 2025.